Ageing and Neurodegenerative Diseases
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Ageing and Neurodegenerative Diseases
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig9

From:  Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer's disease
Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer's disease

Figure 9. PARP-1 inhibitors (1) inhibit PARP-1-promoted phosphorylation of tau and (2) inhibit the PARP-1 facilitated PARylation of neural DNA to retain neural viability[57,203]. Created with BioRender.com. PARP-1: Poly (ADP-ribose) polymerase-1.

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties